TY - JOUR
T1 - Epidemiology and risk factors associated with avascular necrosis in patients with autoimmune diseases
T2 - a nationwide study
AU - Tsai, Hsin Lin
AU - Chang, Jei Wen
AU - Lu, Jen Her
AU - Liu, Chin Su
N1 - Publisher Copyright:
© 2022 The Korean Association of Internal Medicine.
PY - 2022
Y1 - 2022
N2 - Background/Aims: Avascular necrosis (AVN) is a clinical condition characterized by the death of bone components due to interruption in the blood supply. This study aimed to investigate the epidemiology and determine the risk factors for AVN in patients with autoimmune diseases. Methods: We conducted a population-based retrospective cohort analysis using claims data from the Taiwan National Health Insurance Research Database. A total of 49,636 patients with autoimmune diseases between January 1, 2005 and December 31, 2013 were included. Cox regression analysis was used to identify associated risk factors for the development of AVN. Results: A total of 490/49,636 patients (1.0%) developed symptomatic AVN. The systemic lupus erythematosus patients had a higher risk of AVN compared to other autoimmune diseases. AVN was positively correlated with male sex (p < 0.001), alcoholism (p < 0.001), mean daily prednisolone dosage 7.51 to 30 mg (p < 0.001) and > 30 mg (p < 0.001), and total cumulative prednisolone dose 0 g to 5 g (p = 0.002). However, AVN was inversely correlated with cumulative duration of hydroxy-chloroquine exposure > 0.6 years (p < 0.001). Conclusions: Male sex, systemic lupus erythematosus, alcoholism, mean daily corticosteroid > 7.5 mg and a total cumulative dose of corticosteroid 0 to 5 g were independently associated with the development of AVN in autoimmune patients. While hydroxychloroquine use > 0.6 years conferred significant protection against the development of AVN. Clinicians should regularly assess patients with risk factors to enable the early diagnosis of AVN.
AB - Background/Aims: Avascular necrosis (AVN) is a clinical condition characterized by the death of bone components due to interruption in the blood supply. This study aimed to investigate the epidemiology and determine the risk factors for AVN in patients with autoimmune diseases. Methods: We conducted a population-based retrospective cohort analysis using claims data from the Taiwan National Health Insurance Research Database. A total of 49,636 patients with autoimmune diseases between January 1, 2005 and December 31, 2013 were included. Cox regression analysis was used to identify associated risk factors for the development of AVN. Results: A total of 490/49,636 patients (1.0%) developed symptomatic AVN. The systemic lupus erythematosus patients had a higher risk of AVN compared to other autoimmune diseases. AVN was positively correlated with male sex (p < 0.001), alcoholism (p < 0.001), mean daily prednisolone dosage 7.51 to 30 mg (p < 0.001) and > 30 mg (p < 0.001), and total cumulative prednisolone dose 0 g to 5 g (p = 0.002). However, AVN was inversely correlated with cumulative duration of hydroxy-chloroquine exposure > 0.6 years (p < 0.001). Conclusions: Male sex, systemic lupus erythematosus, alcoholism, mean daily corticosteroid > 7.5 mg and a total cumulative dose of corticosteroid 0 to 5 g were independently associated with the development of AVN in autoimmune patients. While hydroxychloroquine use > 0.6 years conferred significant protection against the development of AVN. Clinicians should regularly assess patients with risk factors to enable the early diagnosis of AVN.
KW - Autoimmune disease
KW - Osteonecrosis
KW - Prednisolone
KW - Systemic lupus erythematosus
UR - http://www.scopus.com/inward/record.url?scp=85134033199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134033199&partnerID=8YFLogxK
U2 - 10.3904/kjim.2020.098
DO - 10.3904/kjim.2020.098
M3 - Article
C2 - 35236014
AN - SCOPUS:85134033199
SN - 1226-3303
VL - 37
SP - 864
EP - 876
JO - Korean Journal of Internal Medicine
JF - Korean Journal of Internal Medicine
IS - 4
ER -